Upcoming Webinars

The Future of Personalized Health | Tuesday, September 1st at 6PM EST

The Future of Personalized Health | Tuesday, September 1st at 6PM EST

One gene should never define your health or determine your entire strategy. Human biology is polygenic, which means the bigger picture lies in how multiple genes and pathways work together alongside lifestyle, environment, labs, and symptoms. In this webinar, we’ll challenge simplistic genetic interpretations and explore how DNA360 uses algorithms, pathways, and multi-gene patterns to uncover more meaningful insights. Join us and discover what personalized health can look like when you stop focusing on a single gene.

Why You're Tired | Wednesday, September 2nd at 6PM EST

Why You're Tired | Wednesday, September 2nd at 6PM EST

If you’re searching for one genetic variant that explains why you’re tired, you’re asking the wrong question. Fatigue can reflect patterns across multiple pathways—from mitochondrial function and sleep to stress response, thyroid hormone activation, metabolism, recovery, and oxidative stress. Join us to discover how DNA360 looks beyond individual variants to help uncover the biological patterns that may influence how you produce, use, and recover your energy.

New Genes: Glucose Sensitivity  | Thursday, September 3rd at 6PM EST

New Genes: Glucose Sensitivity | Thursday, September 3rd at 6PM EST

This webinar will explore glucose regulation and insulin sensitivity—how the body manages blood sugar, releases insulin and moves glucose into cells for energy. We will review the DNA360 Glucose Regulation & Insulin Sensitivity assessment, which brings together multiple genetic influences to provide a broader view of metabolic tendencies. We will also examine the individual genes that inform the assessment, including MTNR1B, TCF7L2, SLC30A8, SLC2A2, GIPR and PPARG. Participants will learn how these insights may help personalize nutrition, meal timing, exercise and other lifestyle strategies.

Our Peptide Solution  | Tuesday, September 8th at 6PM EST

Our Peptide Solution | Tuesday, September 8th at 6PM EST

Better peptide decisions begin with understanding the person behind the protocol. Genetic differences can provide valuable context around metabolism, inflammation, detoxification, hormonal balance, recovery, and healthy aging. By combining peptide expertise with genomic insights from DNA360, practitioners can develop more informed, targeted, and individualized approaches.

Join our guests Kyle Mansfield and Deborah Squibb for an engaging discussion on how genomics can inform peptide strategies. Kyle is an anti-aging biohacker and health expert with advanced knowledge of peptide science and evidence-based longevity. Deborah is a Board-Certified Functional Nutritionist with more than 20 years of experience in gut health, peptide therapy, detoxification, and hormonal support. Practitioners and individuals alike will gain practical insights into how genomics and peptide science can work together to inform personalized longevity strategies.

The Truth About Biohacking | Wednesday, September 9th at 6PM EST

The Truth About Biohacking | Wednesday, September 9th at 6PM EST

Fasting worked for them. Cold plunges transformed their mornings. A CGM changed their diet, but does that mean you should do the same? Join us and discover why effective health strategies need to consider genetic tendencies alongside current labs, body metrics, lifestyle, and clinical context instead of blindly following the latest trend.

DNA-U Genomics in Practice: Glucose Sensitivity Part 1 | Thursday, September 10th at 6PM EST

DNA-U Genomics in Practice: Glucose Sensitivity Part 1 | Thursday, September 10th at 6PM EST

This webinar examines the early stages of glucose regulation, from fasting glycaemic control through meal detection, incretin signalling and first-phase insulin secretion. We will review the multigene Glucose Regulation & Insulin Sensitivity assessment and explore the contributions of MTNR1B, TCF7L2, GIPR, SLC2A2 and SLC30A8. Participants will learn how different genetic patterns may present through elevated fasting or postprandial glucose and how to interpret these findings alongside diet, meal timing and relevant laboratory markers.

Testosterone:  Building Healthy Muscle, Bone, Libido, and Much More | Tuesday, September 15th at 6PM EST

Testosterone: Building Healthy Muscle, Bone, Libido, and Much More | Tuesday, September 15th at 6PM EST

Reducing testosterone to sex drive, fertility, or masculinity seriously underestimates what androgen signaling does throughout the body. Testosterone and DHT act through the androgen receptor, influencing everything from muscle and bone to mood, libido, body composition, and prostate biology. Join us as we move beyond the stereotypes and explore the interconnected factors that determine how testosterone is produced, transported, converted, experienced, and cleared.

Weight Loss in the GLP-1 Era  | Wednesday, September 16th at 6PM EST

Weight Loss in the GLP-1 Era | Wednesday, September 16th at 6PM EST

GLP-1 therapies have changed what’s possible in weight management but losing weight and improving health are not always the same thing. Two people can lose the same number of pounds while experiencing very different outcomes in muscle mass, glucose regulation, cravings, and long-term maintenance. Explore how genetics, nutrition, body composition, appetite signaling, and lifestyle can provide a more complete picture of weight management beyond the number on the scale.

Heart Health: Cholesterol and Beyond | Tuesday, September 22nd at 6PM EST

Heart Health: Cholesterol and Beyond | Tuesday, September 22nd at 6PM EST

Reassuring cholesterol numbers can feel like a green light, but they may not reflect every pathway influencing cardiovascular health. Genetic tendencies related to plaque, Lp(a), blood pressure, vascular inflammation, endothelial function, and clotting can paint a more complex picture. Go beyond the standard cholesterol conversation and discover why examining multiple pathways can add valuable context to your cardiovascular risk profile.